|
⚲
|
| Keyboard |
| Opaleye Management Inc
✚
|
|
|---|---|
| CRD # | 124513 |
| SEC # | 801-78700 |
| CIK # | 0001595855 |
| AUM | 802.8 M (2026-02-19) |
| Employees | 4 (100% Investors, 0% Brokers) |
| Phone | 617-229-5085 |
| Address | One Boston Place Boston, MA 02108 |
| Source | [IAPD] [EDGAR] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Transdel Pharmaceuticals Inc | 99.9 | ||
| Liquidia Corp | 88.8 | ||
| Eton Pharmaceuticals Inc | 70.6 | ||
| Sol-Gel Technologies Ltd | 39.6 | ||
| Apogee Therapeutics Inc | 32.8 | ||
| FS Development Corp | 26.9 | ||
| UroGen Pharma Ltd | 25.7 | ||
| Glycomimetics Inc | 24.1 | ||
| Stoke Therapeutics Inc | 22.8 | ||
| Isoray Inc | 19.5 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Opaleye LP | [2013-10-09] | 42.3 M | 789.2 M |
| Filed 2017-06-07 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $50,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 1 | 789.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 1 | 13.6 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 802.8 |
| By Discretionary | ||
| Discretionary | 2 | 802.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 802.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 13.6 | |
| United States Persons | 789.2 | |
| Total | 2 | 802.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| James Silverman | Executive Officer | 3 | 2 | |
| Rrc Management LLC | Executive Officer | 1 | 1 | |
| Opaleye Management Inc | Promoter | 1 | 1 | |
| Opaleye GP LLC | Promoter | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001595855] | |
| 3 | [0001595855] | |
| 4 | [0001595855] | |
| SC 13D | [0001595855] | |
| SC 13G | [0001595855] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.2B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-30 | Buy | 1,850 | $4.99 | 9,232 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-27 | Buy | 10,000 | $5.08 | 50,800 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-26 | Buy | 7,319 | $5.28 | 38,644 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-25 | Buy | 8,581 | $5.43 | 46,595 |
|
Sol-Gel Technologies Ltd SLGL
Ordinary Shares, par value NIS 1.00 per share.
|
2026-03-24 | Buy | 34,665 | $72.00 | 2,495,880 |
|
Sol-Gel Technologies Ltd SLGL
Ordinary Shares, par value NIS 1.00 per share.
|
2026-03-24 | Buy | 5,000 | $72.00 | 360,000 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-24 | Buy | 4,182 | $5.59 | 23,377 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-19 | Buy | 2,094 | $5.71 | 11,957 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-18 | Buy | 2,481 | $5.75 | 14,266 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-16 | Buy | 1,331 | $5.78 | 7,693 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-13 | Buy | 7,358 | $5.75 | 42,308 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-12 | Buy | 5,708 | $5.85 | 33,392 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-09 | Buy | 2,179 | $5.85 | 12,747 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-06 | Buy | 1,900 | $5.80 | 11,020 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-05 | Buy | 42,023 | $5.80 | 243,733 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-05 | Buy | 5,000 | $5.80 | 29,000 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-04 | Buy | 19,795 | $5.81 | 115,009 |
|
Harrow Inc HROW
Common Stock, par value $0.001 per share
|
2026-03-04 | Sell | 134,000 | $39.67 | 5,315,780 |
|
Harrow Inc HROW
Common Stock, par value $0.001 per share
|
2026-03-04 | Sell | 4,263 | $39.67 | 169,113 |
|
Alpha Cognition Inc ACOG
Common Stock, no par value
|
2026-03-03 | Buy | 46,411 | $5.75 | 266,863 |
| showing 20 of 200 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Divisar Capital Management LLC
✚
|
CA | 812.8 M |
|
NAVI Intl-Administradora E Gestora de Recursos Financeiros LTDA
✚
|
810.0 M | |
|
Willing Capital Management Limited
✚
|
806.3 M | |
|
Masters Capital Management LLC
✚
|
GA | 804.6 M |
|
Nokomis Capital LLC
✚
|
TX | 804.2 M |
|
Barnegat Fund Management Inc
✚
|
NJ | 803.4 M |
|
Net Return Asset Management LLC
✚
|
NY | 803.3 M |
|
Hunters Moon Capital LLP
✚
|
802.6 M | |
|
Saturn V Capital Management LP
✚
|
TX | 793.2 M |
|
KR Capital LP
✚
|
NY | 792.4 M |